Business
Avant and IMC Execute BLK MKT(TM) Trademark Licensing Agreement for the German Medical Cannabis Market
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannab...
About this update from Avant Brands Inc
[{"type":"text","content":"\n \n \n \n Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n TORONTO, GLIL YAM,\n \n Israel\n \n and\n \n KELOWNA, BC\n \n .\n \n ,\n \n \n April 4, 2024\n \n \n /CNW/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the \"\n \n Company\n \n \", \"\n \n IMCannabis\n \n \", or \"\n \n IMC\n \n \"), a leading medical cannabis company with operations in\n \n Israel\n \n and\n \n Germany\n \n , and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) (\"\n \n Avant\n \n \") a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the \"\n \n Licensing Agreement\n \n \") granting Adjupharm GmbH, IMC's German subsidiary (\"\n \n Adjupharm\n \n \" or \"\n \n IMC Germany\n \n \", as applicable), the exclusive right to launch the BLK MKT\n \n ™\n \n brand in the German medical cannabis market. The Licensing Agreement constitutes another major milestone with respect to the relationship between the two cannabis companies.\n \n \n \n \n \n \n \n \n \n Under the terms of the Trademark License Agreement, Avant's subsidiary will grant IMC Germany the license to utilize Avant's BLK MKT\n \n TM\n \n cannabis brand for use on their medical cannabis products. All such products will contain cannabis cultivated exclusively by Avant and subsequently exported to\n \n Germany\n \n . The collaboration between the two companies anticipates a positive outcome in the emerging German medical cannabis market, especially following the recent legalization by the government on\n \n April 1\n \n \n st\n \n .\n \n \n The Licensing Agreement signals IMC's commitment to implementing a premium strategy in\n \n Germany\n \n as well as in\n \n Israel\n \n and acts as another step to establish Avant's position in the ultra-premium segment in\n \n Israel\n \n and\n \n Germany\n \n . IMC and Avant have had a productive partnership so far, combining Avant's premium cannab...